Just a question on the timing of FDA in this amnouncement. They are expecting a meeting with FDA in Q1 2025 and clearance anticipated in H2 2025. That clesrance date seems too quick to me. In my other FDA stocks clinical validation studies usually take 12months minimum. Why are they expecting it in 9 month max?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $138.7M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.0¢ | 20.5¢ | $321.5K | 1.516M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 212563 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 400412 | 5 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |